Late-onset lupus nephritis: what is the evidence?迟发性狼疮性肾炎: 证据是什么?KIDNEY RESEARCH AND CLINICAL PRACTICEIF3.82025-11-010OA
Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy非侵入性诊断抗肾素相关足细胞病Kidney International ReportsIF5.72025-05-120OAAI
Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?ANTIBODIESIF2.72025-03-120OAAI
Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathyCLINICAL KIDNEY JOURNALIF4.62024-06-211OAAI
Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?WORLD JOURNAL OF GASTROENTEROLOGYIF5.42024-01-147OAAI
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change diseaseCLINICAL KIDNEY JOURNALIF4.62023-10-191OAAI
Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated VasculitisKIDNEY360IF32023-09-051OAAI
COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?VACCINESIF3.42023-06-246OAAI
Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathyCLINICAL KIDNEY JOURNALIF4.62022-02-244OAAI
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patientsCLINICAL KIDNEY JOURNALIF4.62021-12-218OAAI
Acute interstitial nephritis following SARS-CoV-2 vaccinationCLINICAL KIDNEY JOURNALIF4.62021-12-088OAAI
Opportunities in the cloud or pie in the sky? Current status and future perspectives of telemedicine in nephrologyCLINICAL KIDNEY JOURNALIF4.62020-08-1430OAAI
Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-AnalysisAMERICAN JOURNAL OF NEPHROLOGYIF3.22020-03-1111OAAI
The investigative burden of membranous nephropathy in the UKCLINICAL KIDNEY JOURNALIF4.62019-04-2311OAAI
Management of acute renal failure in the elderly patient - A clinician's guideDRUGS & AGINGIF3.82008-01-0158PRE